Warning letter
Baptist Health Medical Towers Pharmacy and Infusion Services: warning letter of Sep 12, 2017
FDA warning letter 527394 · Dallas District Office
Key facts
| Reference number | 527394 |
|---|---|
| Company | Baptist Health Medical Towers Pharmacy and Infusion Services |
| Subject | Drug Product/Adulterated |
| Issue date | Sep 12, 2017 |
| Posted date | Sep 26, 2017 |
| Issuing office | Dallas District Office |
| Product type | Drugs |
| Inspection city | Little Rock |
| Inspection ZIP | 72205 |
| Inspection start date | Apr 11, 2016 |
| Letter on fda.gov | fda.gov |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: